Alexander GC - Search Results

1

Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.

Alexander GC, Budnitz D, Hughes C, Maas R, Mair A, McDonald EG, Meid AD, Payne R, Seidling HM, Shakir S, Suissa S, Tannenbaum C, Schneeweiss S, Dreischulte T. Alexander GC, et al. Drug Saf. 2024 Jan;47(1):103-111. doi: 10.1007/s40264-023-01362-9. Epub 2023 Nov 2. Drug Saf. 2024. PMID: 37917316 No abstract available.

2

Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.

Fain K, Alexander GC. Fain K, et al. Among authors: alexander gc. Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1258-62. doi: 10.1002/pds.3514. Epub 2013 Sep 22. Pharmacoepidemiol Drug Saf. 2013. PMID: 24115318 No abstract available.

3

Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin.

Fain K, Alexander GC. Fain K, et al. Among authors: alexander gc. Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):440-1. doi: 10.1002/pds.3577. Pharmacoepidemiol Drug Saf. 2014. PMID: 24706420 No abstract available.

4

Emergency department visits by adults for psychiatric medication adverse events.

Hampton LM, Daubresse M, Chang HY, Alexander GC, Budnitz DS. Hampton LM, et al. Among authors: alexander gc. JAMA Psychiatry. 2014 Sep;71(9):1006-14. doi: 10.1001/jamapsychiatry.2014.436. JAMA Psychiatry. 2014. PMID: 25006837 Free PMC article.

5

Emergency department visits by children and adolescents for antipsychotic drug adverse events.

Hampton LM, Daubresse M, Chang HY, Alexander GC, Budnitz DS. Hampton LM, et al. Among authors: alexander gc. JAMA Psychiatry. 2015 Mar;72(3):292-4. doi: 10.1001/jamapsychiatry.2014.2412. JAMA Psychiatry. 2015. PMID: 25588054 Free PMC article. No abstract available.

6

Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.

Baksh SN, Gellad WF, Alexander GC. Baksh SN, et al. Among authors: alexander gc. Drug Saf. 2016 May;39(5):375-80. doi: 10.1007/s40264-015-0389-2. Drug Saf. 2016. PMID: 26798050

7

Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory.

Dusetzina SB, Busch AB, Conti RM, Donohue JM, Alexander GC, Huskamp HA. Dusetzina SB, et al. Among authors: alexander gc. Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1251-60. doi: 10.1002/pds.3272. Epub 2012 May 3. Pharmacoepidemiol Drug Saf. 2012. PMID: 22553074 Free PMC article.

8

Impact of a drug utilization review program on high-risk use of prescription controlled substances.

Daubresse M, Gleason PP, Peng Y, Shah ND, Ritter ST, Alexander GC. Daubresse M, et al. Among authors: alexander gc. Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):419-27. doi: 10.1002/pds.3487. Epub 2013 Jul 24. Pharmacoepidemiol Drug Saf. 2014. PMID: 23881609

9

Impact of abuse-deterrent OxyContin on prescription opioid utilization.

Hwang CS, Chang HY, Alexander GC. Hwang CS, et al. Among authors: alexander gc. Pharmacoepidemiol Drug Saf. 2015 Feb;24(2):197-204. doi: 10.1002/pds.3723. Epub 2014 Nov 13. Pharmacoepidemiol Drug Saf. 2015. PMID: 25393216

10

Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010.

Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Kaufmann CN, et al. Among authors: alexander gc. Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):637-45. doi: 10.1002/pds.3951. Epub 2015 Dec 29. Pharmacoepidemiol Drug Saf. 2016. PMID: 26711081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters